CCL vs IMDX · P/E 15, rev $12.83B vs rev $271.0K
Carnival Corporation (CCL) versus Insight Molecular Diagnostics Inc. (IMDX) — a side-by-side from cached financials, not a winner call.
Carnival Corporation (CCL) is a travel services company listed on US.
Insight Molecular Diagnostics Inc. (IMDX) is a diagnostics & research company listed on US.
Latest reported CCL revenue for 2026-05-31 was $12.83B. Net income was $795.0M. CCL currently screens at market cap $39.74B and trailing P/E 15.3.
Latest reported IMDX revenue for 2026-06-30 was $271.0K. Net income was -$15.6M. IMDX currently screens at market cap $0.
CCL currently screens at market cap $39.74B and trailing P/E 15.3. IMDX currently screens at market cap $0.
Not investment advice. Open the CCL and IMDX stock pages for the full models.
Not investment advice.